DR. MATTHEW JOSEPH ROWLEY MD NPI 1871538702

NPI Details

DR. Matthew Joseph Rowley, MD is a specialist in Lufkin, TX with 32 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Matthew Joseph Rowley, MD NPI is 1871538702. The provider is registered as an individual entity type and is a single specialty group.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

107 CHRISTIE STREET
LUFKIN, TX
ZIP 75904-575
Phone: (936) 634-9648
Fax: (936) 634-9663

The NPI 1871538702 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 45D0888204 - physician office with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS:J7345)
• Ultrasonic guidance for placement of radiation therapy fields (HCPCS:G6001)
• Obtaining data needed to develop the optimal radiation treatment, 1 treatment area (HCPCS:77280)
• Superficial and/or low voltage radiation treatment delivery (HCPCS:77401)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Radiation treatment management, 5 treatment sessions (HCPCS:77427)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Continuing radiation therapy consultation per week (HCPCS:77336)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Calculation of radiation therapy dose (HCPCS:77300)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Design and construction of complex radiation treatment device (HCPCS:77334)
• Simple radiation therapy planning (HCPCS:77261)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Punch biopsy, first skin growth (HCPCS:11104)
• Application of light to destroy precancer skin growth (HCPCS:96567)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Design and construction of simple radiation treatment device (HCPCS:77332)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:17281)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks (HCPCS:17311)
• Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) (HCPCS:J7308)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:17280)
• Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11402)
• Intermediate radiation therapy planning (HCPCS:77262)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:17271)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• Removal of cancer skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11601)
• Obtaining data needed to develop the optimal radiation treatment, 2 treatment areas (HCPCS:77285)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm (HCPCS:12052)
• Removal of skin tag, 1-15 skin tags (HCPCS:11200)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less (HCPCS:17260)
• Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11301)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11641)
• Shaving of skin growth of body, arms, or legs, 0.5 cm or less (HCPCS:11300)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11642)
• Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm (HCPCS:12042)
• Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved (HCPCS:77290)
• Complex radiation therapy planning (HCPCS:77263)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less (HCPCS:17270)
• Varicose vein removal (HCPCS:NAN08)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/17/2006 and was last updated on 6/13/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.